Evidence map›Paper›PMID 33408209›Full record

ArticleBMJ open2021

Recommendations for SARS-CoV-2/COVID-19 testing: a scoping review of current guidance.

Ingrid Arevalo-Rodriguez, Pamela Seron, Diana Buitrago-García, Agustin Ciapponi, Alfonso Muriel, Paula Zambrano-Achig, Rosa Del Campo, Juan Carlos Galán-Montemayor, Daniel Simancas-Racines, Jose A Perez-Molina and 2 more

Open access · goldAbstract readScoping Review
In one paragraph

Article in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 22 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. [Security protocols adapted to COVID-19 in elective surgery thru 2021].Revista medica del Instituto Mexicano del Seguro Social · 2022
    Article
  9. Review
  10. Challenges Faced in Large-Scale Nucleic Acid Testing during the Sudden Outbreak of the B.1.617.2 (Delta).International journal of environmental research and public health · 2022
    Article
  11. Review
  12. Article
  13. Observational
  14. Article
  15. Rationale for reverse-transcription polymerase chain reaction for SARS-CoV-2 screening in patients undergoing in-laboratory sleep studies.Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 6 countries.

Ingrid Arevalo-RodriguezClinical Biostatistics Unit, Hospital Universitario Ramón y Cajal, IRYCIS, CIBER of Epidemiology and Public Health, Madrid, Spain.ORCID 0000-0002-7326-4504
Pamela SeronDepartment of Internal Medicine, Faculty of Medicine, Universidad de La Frontera, Temuco, Chile.
Diana Buitrago-GarcíaInstitute of Social and Preventive Medicine (ISPM), University of Bern, Switzerland, Bern, Switzerland.
Agustin CiapponiInstituto de Efectividad Clínica y Sanitaria (IECS-CONICET), Buenos Aires, Argentina.
Alfonso MurielClinical Biostatistics Unit, Hospital Universitario Ramón y Cajal, CIBER of Epidemiology and Public Health, Madrid, Spain.ORCID 0000-0002-4805-4011
Paula Zambrano-AchigCentro de investigación en Salud Pública y Epidemiología Clínica (CISPEC). Facultad de Ciencias de la Salud "Eugenio Espejo", Universidad UTE, Quito, Ecuador.
Rosa Del CampoDepartment of Microbiology, Ramón y Cajal University Hospital, Ramón y Cajal Health Research Institute (IRYCIS), Madrid, Spain.
Juan Carlos Galán-MontemayorDepartment of Microbiology, Ramón y Cajal University Hospital. Ramón y Cajal Health Research Institute (IRYCIS), CIBER of Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Daniel Simancas-RacinesCentro de investigación en Salud Pública y Epidemiología Clínica (CISPEC). Facultad de Ciencias de la Salud "Eugenio Espejo", Universidad UTE, Quito, Ecuador.
Jose A Perez-MolinaInfectious Diseases Department, National Referral Centre for Tropical Diseases, Hospital Universitario Ramón y Cajal, IRYCIS, Madrid, Spain.
Khalid Saeed KhanDepartment of Preventive Medicine and Public Health, Faculty of Medicine, University of Granada, CIBER of Epidemiology and Public Health, Granada, Spain.
Javier ZamoraClinical Biostatistics Unit, Hospital Universitario Ramón y Cajal, CIBER of Epidemiology and Public Health, Madrid, Spain j.zamora.1@bham.ac.uk.ORCID 0000-0003-4901-588X
Centro de Investigación Biomédica en Red · ESInstituto Cajal · ESUniversidad UTE · ECConsejo Nacional de Investigaciones Científicas y Técnicas · ARInstituto Ramón y Cajal de Investigación Sanitaria · ESUniversidad de Granada · ESUniversidad de La Frontera · CLUniversity of Bern · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTesting used in screening, diagnosis and follow-up of COVID-19 has been a subject of debate. Several organisations have developed formal advice about testing for COVID-19 to assist in the control of the disease. We collated, delineated and appraised current worldwide recommendations about the role and applications of tests to control SARS-CoV-2/COVID-19.

methodsWe searched for documents providing recommendations for COVID-19 testing in PubMed, EMBASE, LILACS, the Coronavirus Open Access Project living evidence database and relevant websites such as TRIP database, ECRI Guidelines Trust, the GIN database, from inception to 21 September 2020. Two reviewers applied the eligibility criteria to potentially relevant citations without language or geographical restrictions. We extracted data in duplicate, including assessment of methodological quality using the Appraisal of Guidelines for Research and Evaluation-II tool.

resultsWe included 47 relevant documents and 327 recommendations about testing. Regarding the quality of the documents, we found that the domains with the lowest scores were 'Editorial independence' (Median=4%) and 'Applicability' (Median=6%). Only six documents obtained at least 50% score for the 'Rigour of development' domain. An important number of recommendations focused on the diagnosis of suspected cases (48%) and deisolation measures (11%). The most frequently recommended test was the reverse transcription-PCR (RT-PCR) assay (87 recommendations) and the chest CT (38 recommendations). There were 22 areas of agreement among guidance developers, including the use of RT-PCR for SARS-Cov-2 confirmation, the limited role of bronchoscopy, the use chest CT and chest X-rays for grading severity and the co-assessment for other respiratory pathogens.

conclusionThis first scoping review of recommendations for COVID-19 testing showed many limitations in the methodological quality of included guidance documents that could affect the confidence of clinicians in their implementation. Future guidance documents should incorporate a minimum set of key methodological characteristics to enhance their applicability for decision making.

Indexed as

Practice Guidelines as TopicSARS-CoV-2COVID-19COVID-19 TestingHumansPandemicsTomography, X-Ray Computeddiagnostic microbiologyepidemiologyprotocols & guidelines

Identifiers

PMID33408209
PMCPMC7789202
OpenAlexW3119021675

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.